Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
India
(8/week)
Singapore
(2/week)
China, P. R.
(1/week)
Philippines
(1/week)
View all
(31/week)
News
United States
(1121/week)
Manufacturing
(562/week)
Technology
(1133/week)
Energy
(412/week)
Other Manufacturing
(384/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Blinatumomab
Jan 02, 2020
Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China
Sep 24, 2019
Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
Jun 16, 2019
Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019
Feb 19, 2019
Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial
Feb 19, 2019
Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris
Jan 22, 2019
European Commission Approves BLINCYTO® (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Sep 24, 2018
BLINCYTO® (blinatumomab) Approved In Japan For The Treatment Of Relapsed Or Refractory B-cell Acute Lymphoblastic Leukemia
Aug 29, 2018
European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Jun 19, 2018
Amgen Receives European Commission Approval To Add Overall Survival Data To BLINCYTO® (blinatumomab) Label
Mar 29, 2018
FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children
Feb 14, 2018
Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO® (blinatumomab)
Jun 23, 2017
European Hematology Association: The More the T-lymphocytes Differ, the More Effectively They Fight Against Leukemia
Latest News
Sep 1, 2024
Insta Max 20K Puffs Vape: The Future of Vaping Has Arrived
Sep 1, 2024
Kodiak Gas Services Announces 2023 Schedule K-3 Investor Tax Packages for CSI Compressco LP Are Available...
Sep 1, 2024
SEEDS Academy and Visa Partner to Empower Youth and Promote Sustainability Through Innovative Online Courses
Sep 1, 2024
Japan protests Chinese naval intrusion into territorial waters
Aug 31, 2024
Suzano completes purchase of 15% stake in Lenzing AG
Aug 31, 2024
Noble Corporation plc announces changes to its share capital including share repurchases for the month of...
Aug 31, 2024
FP Markets Wins Double at FMPS 2024
Aug 31, 2024
Kenya airport workers' union delays strike again
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
View All Events